Amazon has 100s of Canada Day deals ahead of Prime Day 2025 — save $100s on home, tech, kitchen and more
Canada Day long weekend is here, and so are some seriously impressive Amazon Canada deals. While Prime Day 2025 is still a couple of weeks away (it officially kicks of July 8 and runs through July 11), that doesn't mean you have to wait to start saving.
Shop the best early Amazon Prime Day deals by category below:
Tech deals: Shop all tech deals
Home deals: Shop all home deals
Kitchen deals: Shop all kitchen deals
Beauty deals: Shop all beauty deals
Fashion deals: Shop all fashion deals
Personal care deals: Shop all personal care deals
Lawn and garden deals: Shop all lawn and garden deals
Right now, you can score big savings on everything from home gadgets and beauty must-haves to bestselling tech and more. Whether you're relaxing by the pool or scrolling while BBQing, these early bargains are worth taking a peek at. We've rounded up the best long weekend deals to shop now — with discounts of up to 91 per cent off (yes, seriously!).
Not in the Amazon mood? No worries:
Lululemon just dropped a ton of new We Made Too Much scores in time for Canada Day
Best Buy's Black Friday in Summer sale is on now — save $100s
Silk & Snow is having an epic Canada Day sale — save on bedding, bed frames, furniture & moreIn this guide: Early Prime Day home deals | Early Prime Day tech deals | Early Prime Day kitchen deals | Early Prime Day beauty & wellness deals
By the way — did we mention that with every Amazon or Prime Video purchase of $20 or more, there's a chance to win huge prizes? Amazon's Giftmania is on through the end of Prime Day, July 11. Click here for all the details.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
One Bitcoin Is Over $100,000 — 5 Ways New Investors Can Afford It
Bitcoin's price has soared past $100,000, making headlines and sparking new interest among Americans who want to get in on the action. For many, the idea of buying a whole bitcoin at this price seems impossible. But, according to Anthony Georgiades, founder and general partner at Innovating Capital, 'You don't need to buy a full bitcoin to get started.' Read More: Try This: Most major exchanges and popular payment apps allow investors to buy fractions of a bitcoin, making it possible to invest with small amounts. New investors can also use traditional brokerage accounts, bitcoin ETFs, or even invest in companies involved in the crypto industry. With so many options available, here are five smart ways to afford bitcoin when the price tag for one coin is sky-high. Georgiades explained that 'fractional investing just means you're buying a piece of a bitcoin rather than the whole thing.' It is the easiest way for new investors to afford bitcoin, since you can buy as little as $5 or $10 worth. Bitcoin is divided into units called 'satoshis,' allowing even a $10 investment to give you exposure to this digital asset. Most major exchanges like Coinbase, as well as apps like Cash App and PayPal, let you purchase small fractions, making it accessible for nearly anyone. Before you buy, compare fees and minimums on different platforms, since costs can add up with small purchases. Always use a reputable exchange and consider moving your bitcoin to a secure wallet as your holdings grow. See Next: Payment apps like PayPal, Venmo, and Cash App have made buying bitcoin as easy as sending money to a friend. According to Gadinsider, these apps allow you to buy bitcoin in small amounts, track your investment, and even transfer your crypto to another wallet. Georgiades said, 'Apps like Cash App, PayPal, and Venmo also make it easy to buy tiny amounts.' To get started, just select bitcoin in the app, enter the amount you want to buy, and follow the instructions. You can store your bitcoin in the app or move it to another wallet for added security. This approach is ideal for beginners who want a simple, familiar way to start investing without dealing with complicated exchanges or wallets. If you prefer a more traditional route, consider investing in a bitcoin exchange-traded fund (ETF) or exchange-traded product (ETP). These funds let you track bitcoin's price without having to manage wallets or private keys. Georgiades explained, 'You can invest through bitcoin ETFs or ETPs using a regular brokerage account.' Bitcoin ETFs are easy to buy, offer low fees, and allow you to purchase fractional shares, making them accessible for smaller budgets. You will see returns that closely match bitcoin's price, minus the fund's expense ratio. This method is less risky than holding bitcoin directly, but you still need to be aware that the value of your investment will rise and fall with bitcoin's price. Dollar-cost averaging (DCA) is a strategy where you invest a fixed amount in bitcoin on a regular schedule, like weekly or monthly. Georgiades described DCA as 'a simple strategy: you invest a set amount on a regular schedule regardless of Bitcoin's price.' According to Forbes, this approach helps smooth out the ups and downs of the market and takes emotion out of investing. DCA can help you avoid the risk of buying at a market peak, but it does not protect you from a long-term drop in bitcoin's price. Be mindful of trading fees, as frequent small purchases can add up over time. Another way to get exposure to bitcoin is by buying shares in companies involved in the crypto industry, such as exchanges like Coinbase or mining firms. Georgiades pointed out that 'another indirect way is by buying stocks in crypto-related companies like Coinbase or mining firms.' You can also invest in blockchain ETFs, which focus on companies building the technology behind bitcoin. This method gives you exposure to the broader crypto ecosystem without owning bitcoin directly. While it's not the same as holding bitcoin, it can be a good way to participate in the industry's growth, especially if you are more comfortable with traditional stocks. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 How Much Money Is Needed To Be Considered Middle Class in Your State? Mark Cuban Says Trump's Executive Order To Lower Medication Costs Has a 'Real Shot' -- Here's Why This article originally appeared on One Bitcoin Is Over $100,000 — 5 Ways New Investors Can Afford It
Yahoo
33 minutes ago
- Yahoo
Could The Market Be Wrong About W.W. Grainger, Inc. (NYSE:GWW) Given Its Attractive Financial Prospects?
W.W. Grainger (NYSE:GWW) has had a rough month with its share price down 5.4%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Specifically, we decided to study W.W. Grainger's ROE in this article. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for W.W. Grainger is: 52% = US$2.0b ÷ US$3.8b (Based on the trailing twelve months to March 2025). The 'return' refers to a company's earnings over the last year. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.52 in profit. Check out our latest analysis for W.W. Grainger Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. Firstly, we acknowledge that W.W. Grainger has a significantly high ROE. Secondly, even when compared to the industry average of 13% the company's ROE is quite impressive. Under the circumstances, W.W. Grainger's considerable five year net income growth of 23% was to be expected. We then performed a comparison between W.W. Grainger's net income growth with the industry, which revealed that the company's growth is similar to the average industry growth of 19% in the same 5-year period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about W.W. Grainger's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. W.W. Grainger has a really low three-year median payout ratio of 21%, meaning that it has the remaining 79% left over to reinvest into its business. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number. Besides, W.W. Grainger has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. Based on the latest analysts' estimates, we found that the company's future payout ratio over the next three years is expected to hold steady at 21%. Regardless, W.W. Grainger's ROE is speculated to decline to 40% despite there being no anticipated change in its payout ratio. On the whole, we feel that W.W. Grainger's performance has been quite good. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
34 minutes ago
- Associated Press
ELV DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the 'Class Period'), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Elevance class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that, with the Medicaid redetermination process nearly complete, defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in Elevance's guidance for the year. These representations were materially false or misleading. In truth, the redeterminations were causing the acuity and utilization of Elevance's Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs. This shift was occurring to a degree that was not reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Elevance class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
